Trodelvy: payments to doctors
Payments that named Trodelvy as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $11M
- Providers
- 10,237
- Transactions
- 43,075
- Average per transaction
- $255
The per-transaction average — $255 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,237 providers the average total is $1,075, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Gilead | $10,765,250 | 97.8% |
| Immunomedics, Inc. | $239,938 | 2.2% |